At present there is no efficient vaccine against malaria, which is caused by the plasmodium parasite. Now researchers from two laboratories in France have successfully vaccinated and protected mice using a new strategy they developed.
A team of researchers from the University of Science and Technology at Lille and the National Institutes of Health in the US have demonstrated in animals their vaccine strategy based on the ingestion of genetically modified starch.
They protected the mice from malaria by feeding them starch derived from a green algae called chlamydomonas reinhardtii that was genetically modified to carry the vaccine proteins (antigens) that will elicit antibodies against the malaria parasite.
They say their findings on the use of the recombinant anti-malaria vaccine open up a new method for a simple and safe vaccination for children at risk. According to the WHO, every year malaria kills one million people, mostly young children.
Although this is “an interesting concept”, edible vaccines in general have not taken off for a variety of reasons, a leading biochemist and a malaria researcher at the Indian Institute of Science in Bangalore said.
“All antigens do not work through the oral route,” he said, adding that there is also the problem of adjusting dose and schedule in an edible product, unlike the conventional vaccine, which is directly injected into blood in a defined concentration and dosage.
“Nevertheless, it would be interesting to see whether a proof of principle can be obtained (with the edible malaria vaccine) in the human,” he said.
For their animal experiments, the researchers used three distinct plasmodium antigens that have shown their efficacy in “conventional” vaccinations as vaccine candidates against malaria.
They fused these antigens to an enzyme called GBSS in starch grains purified from the green algae through genetic engineering. These “modified” starch grains were then fed to the mice that had been previously challenged with a lethal dose of a malaria parasite called plasmodium berghei.
The researchers showed that the mice vaccinated by these starch grains were protected from malaria.
They said the animal vaccine studies suggested that the levels of transgenic starch antigens used were “sufficient to confer substantial protection against lethal plasmodium berghei in mice”.
Additionally, in test-tube studies, they showed that the transgenic starch elicited antibodies to plasmodium falciparum, another parasite that causes cerebral malaria.
The algae C reinhardtii thus provides an ideal expression system for the production of recombinant vaccine, the scientists reported. “Aside from the tremendous advantage of producing clinically relevant antigens in starch, transgenic algae can also be generated quickly,” they said.
Dear TNT Reader,
At The News Tribe, our mission is to bring you free, independent, and unbiased news and content that keeps you informed and empowered. We are committed to upholding the highest standards of journalism, as we understand that we are a platform for truth.
Apart from independent global news coverage, we also commit our unique focus on the Muslim world. In an age marked by the troubling rise of Islamophobia and widespread misrepresentation of Muslims in Western media, we strive to provide accurate and fair coverage.
But to continue doing so, we need your support. Even a small donation of 1$ can make a big difference. Your contribution will help us maintain the quality of our news and counteract the negative narratives that are so prevalent.
Please consider donating today to ensure we can keep delivering the news that matters. Together, we can make a positive impact on the world, and work towards a more inclusive, informed global society.
Donate Monthly Subscription Annual Subscription